(Q43849054)

27 November 2017

Approaches to handling pharmacodynamic baseline responses (English)

1 reference

27 November 2017

1 reference

3

Mats O Karlsson

1 reference

27 November 2017

Chantaratsamon Dansirikul

series ordinal

1

1 reference

PubMed ID

18446428

27 November 2017

Hanna E Silber

series ordinal

2

1 reference

27 November 2017

30 April 2008

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

27 November 2017

1 reference

27 November 2017

35

1 reference

27 November 2017

269-283

1 reference

27 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10928-008-9088-2

27 November 2017

0 references

cites work

Role of baseline parameters in determining indirect pharmacodynamic responses.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.

1 reference

12 December 2020

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

1 reference

12 December 2020

A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection

1 reference

12 December 2020

Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study.

1 reference

12 December 2020

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS

1 reference

12 December 2020

The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.

1 reference

12 December 2020

Population pharmacodynamic analysis of octreotide in acromegalic patients

1 reference

12 December 2020

An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs

1 reference

12 December 2020

Design of biological equivalence programs for therapeutic biotechnology products in clinical development: a perspective

1 reference

12 December 2020

Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions

1 reference

12 December 2020

10.1007/S10928-008-9088-2

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

18446428